Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

nemluvio

Class 5Status: Accepted & Advertised
Trademark Logo
Application Number6276371
Trademark Status
Accepted & Advertised
Trademark Class5
Application Date2023-12-01
Proprietor NameGalderma Holding SA
Appropriate OfficeIR DIVISION
StateSTATE NOT SPECIFIED
Trademark TypeDEVICE
User DetailsProposed to be used
Goods And Services Details[CLASS : 5] Pharmaceutical preparations; pharmaceutical preparations in the field of dermatology; pharmaceutical preparations for use with skin care; pharmaceutical preparations for the treatment of immune related inflammatory diseases; pharmaceutical preparations for the treatment of atopic dermatitis and prurigo nodularis.

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about nemluvio.

What is the status of trademark application 6276371?
The current status of trademark application 6276371 for nemluvio is Accepted & Advertised.
What is the trademark class of nemluvio?
nemluvio is registered under trademark class 5.
Who is the proprietor of nemluvio?
The proprietor of nemluvio is Galderma Holding SA.
When was trademark application 6276371 filed?
Trademark application 6276371 for nemluvio was filed on 2023-12-01.